Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00615069 · ClinicalTrials.gov registry record · Phase 2
Study of the Large Diameter GORE EXCLUDER® AAA Endoprosthesis in Abdominal Aneurysms
A Phase 2 study, sponsored by W.L.Gore & Associates.
- Completed
- Registry status
- Phase 2
- Development phase
- 35
- Enrollment target
NCT00615069: Completed Phase 2 study, sponsored by W.L.Gore & Associates.
NCT00615069 is a Phase 2 study that has completed, run by W.L.Gore & Associates. The registered enrollment target is 35 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00615069, a Phase 2 study, has completed, sponsored by W.L.Gore & Associates.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 35 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the safety and efficacy of the 31 mm GORE EXCLUDER® AAA Endoprosthesis in the treatment of infrarenal abdominal aortic aneurysms
Interventions
- DEVICE 31 mm GORE EXCLUDER® AAA Endoprosthesis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2006-05 |
| Est. Completion | 2014-06 |
| Phase | Phase 2 |
What the finished NCT00615069 record still lists
NCT00615069 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 1 intervention - of which 31 mm GORE EXCLUDER® AAA Endoprosthesis is the first listed.
NCT00615069 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00615069 about?
NCT00615069 is a clinical study titled "Study of the Large Diameter GORE EXCLUDER® AAA Endoprosthesis in Abdominal Aneurysms". The purpose of this study is to assess the safety and efficacy of the 31 mm GORE EXCLUDER® AAA Endoprosthesis in the treatment of infrarenal abdominal aortic aneurysms
What is the current status of trial NCT00615069?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 35 participants. The study started on 2006-05. Estimated completion is 2014-06.
What interventions are being tested in trial NCT00615069?
The interventions under investigation include: 31 mm GORE EXCLUDER® AAA Endoprosthesis (DEVICE).
Who is sponsoring clinical trial NCT00615069?
This trial is sponsored by W.L.Gore & Associates, which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00615069's enrollment target sits among peer trials
35 1524th of 2000 higher than 462 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia